Fenestra HDVC

Description

Achieve Clearer Soft Tissue Visualization with Hepatocyte Selective Fenestra HDVC™ for Micro-CT Imaging.

Fenestra HDVC™ is a biomimetic nanoemulsion designed to provide excellent soft tissue contrast in microCT imaging. Ideal for preclinical research, Fenestra HDVC™ ensures high-quality imaging for better analysis of tumors, organs, and other soft tissues.

---

Why Choose Fenestra HDVC™?

Biomimetic Composition
Fenestra HDVC™ is designed to closely mimic naturally circulating chylomicron remnants allowing for the only hepatocyte selective contrast agent for preclinical research.

High-Resolution Imaging
When used with a microCT system, Fenestra HDVC™ enhances soft tissue visibility enabling imaging of organs in PET-CT or SPECT-CT data sets, negative contrast from liver tumors, and vascular systems.

Safe & Non-Toxic
This contrast agent is based in modified vitamin E formulation making it suitable for longitudinal in vivo imaging studies.

---

How Fenestra HDVC™ Benefits Your Research

• Tumor Detection: Enhances the visualization of liver and pancreatic tumors, making it easier to identify even small masses for oncology studies.
  
• Organ Imaging: Ideal for detailed imaging of organ structures, supporting drug biodistribution studies using multimodal imaging.
  
• Supports Therapeutic Evaluation: Helps visualize subtle tissue changes, making it useful for evaluating therapeutic interventions.
  

Versatile Applications: Suitable for a wide range of preclinical studies, including cancer research, drug development, and therapy assessments.

Interested in testing out Fenestra HDVC for liver tumors? Ask us about our CRO services for scanning excised livers with microCT.